CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...
European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...
The European Patent Office’s latest report shows patent filings holding steady, with computer technology leading growth.
The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.
With nearly 800 cases adjudicated or pending thus far at the Unified Patent Court (UPC), a possible procedural gap has ...
European Patent Office (EPO) received nearly 200,000 patent applications last year, with 6.6% coming from the Republic of Korea Strongest growth globally ...
3d
Vietnam Investment Review on MSNPatent Index 2024: Japan ranks 3rd in European patent applicationsAccording to the latest Patent Index 2024, published today by the European Patent Office (EPO), Japan ranked third worldwide, following the United States and Germany.
CureVac (CVAC) announced that the European Patent Office has confirmed the validity of the company’s European patent EP 3 708 668 B1 subject to ...
European Patent Office (EPO) received nearly 200,000 patent applications last year, with 6.6% coming from the Republic of Korea Strongest growth globally came from electrical machinery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results